Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 0228-2918

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 0228-2918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E1bfe0c2-figure-01 (Image 1)

Chemical structure of Diltiazem Hydrochloride showing its molecular configuration with labeled functional groups and atoms, along with its molecular formula C22H26N2O4S•HCl displayed on the image.*

FDA Label Image

E1bfe0c2-figure-02 (Image 2)

Diltiazem Hydrochloride 360 mg extended-release capsule blister pack from Actavis Pharma, Inc. The image shows a silver foil blister containing ten capsules arranged in two rows of five. Each capsule is oblong with a white and red body.*

FDA Label Image

360mg 90s (Image 3)

Label for Diltiazem Hydrochloride Extended-Release Capsules, USP 360 mg from Actavis Pharma, Inc., showing a package size of 90 capsules for oral use. The label includes the NDC number 0228-2918-09, dosage form, strength, dispensing instructions, storage conditions, warning to keep out of reach of children, and manufacturing information by Teva Pharmaceuticals USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.